ResMed Current Ratio 2010-2025 | RMD
Current and historical current ratio for ResMed (RMD) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. ResMed current ratio for the three months ending March 31, 2025 was 3.41.
| ResMed Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-03-31 | $3.21B | $0.94B | 3.41 |
| 2024-12-31 | $2.84B | $0.85B | 3.33 |
| 2024-09-30 | $2.64B | $0.90B | 2.92 |
| 2024-06-30 | $2.36B | $0.91B | 2.59 |
| 2024-03-31 | $2.35B | $0.77B | 3.04 |
| 2023-12-31 | $2.38B | $0.76B | 3.11 |
| 2023-09-30 | $2.31B | $0.77B | 2.99 |
| 2023-06-30 | $2.37B | $0.76B | 3.12 |
| 2023-03-31 | $2.34B | $0.76B | 3.07 |
| 2022-12-31 | $2.33B | $0.73B | 3.17 |
| 2022-09-30 | $2.03B | $0.69B | 2.94 |
| 2022-06-30 | $1.93B | $0.69B | 2.80 |
| 2022-03-31 | $1.70B | $0.67B | 2.55 |
| 2021-12-31 | $1.55B | $0.62B | 2.49 |
| 2021-09-30 | $1.59B | $0.62B | 2.54 |
| 2021-06-30 | $1.58B | $0.91B | 1.73 |
| 2021-03-31 | $1.47B | $0.88B | 1.67 |
| 2020-12-31 | $1.45B | $0.58B | 2.51 |
| 2020-09-30 | $1.54B | $0.59B | 2.61 |
| 2020-06-30 | $1.52B | $0.60B | 2.53 |
| 2020-03-31 | $1.47B | $0.55B | 2.67 |
| 2019-12-31 | $1.30B | $0.50B | 2.60 |
| 2019-09-30 | $1.16B | $0.55B | 2.11 |
| 2019-06-30 | $1.15B | $0.56B | 2.06 |
| 2019-03-31 | $1.10B | $0.46B | 2.38 |
| 2018-12-31 | $1.06B | $0.44B | 2.44 |
| 2018-09-30 | $1.09B | $0.42B | 2.58 |
| 2018-06-30 | $1.07B | $0.51B | 2.09 |
| 2018-03-31 | $1.60B | $0.46B | 3.48 |
| 2017-12-31 | $1.75B | $1.36B | 1.29 |
| 2017-09-30 | $1.66B | $0.35B | 4.72 |
| 2017-06-30 | $1.64B | $0.36B | 4.57 |
| 2017-03-31 | $1.61B | $0.34B | 4.77 |
| 2016-12-31 | $1.52B | $0.68B | 2.23 |
| 2016-09-30 | $1.48B | $0.62B | 2.38 |
| 2016-06-30 | $1.42B | $0.64B | 2.23 |
| 2016-03-31 | $1.40B | $0.29B | 4.89 |
| 2015-12-31 | $1.35B | $0.27B | 5.09 |
| 2015-09-30 | $1.53B | $0.26B | 5.96 |
| 2015-06-30 | $1.41B | $0.27B | 5.28 |
| 2015-03-31 | $1.55B | $0.26B | 6.06 |
| 2014-12-31 | $1.56B | $0.26B | 6.00 |
| 2014-09-30 | $1.54B | $0.25B | 6.04 |
| 2014-06-30 | $1.56B | $0.27B | 5.77 |
| 2014-03-31 | $1.56B | $0.25B | 6.33 |
| 2013-12-31 | $1.56B | $0.24B | 6.44 |
| 2013-09-30 | $1.56B | $0.61B | 2.55 |
| 2013-06-30 | $1.45B | $0.57B | 2.52 |
| 2013-03-31 | $1.58B | $0.58B | 2.72 |
| 2012-12-31 | $1.53B | $0.25B | 6.09 |
| 2012-09-30 | $1.45B | $0.25B | 5.73 |
| 2012-06-30 | $1.36B | $0.25B | 5.38 |
| 2012-03-31 | $1.33B | $0.26B | 5.15 |
| 2011-12-31 | $1.25B | $0.23B | 5.46 |
| 2011-09-30 | $1.14B | $0.23B | 5.06 |
| 2011-06-30 | $1.29B | $0.21B | 6.19 |
| 2011-03-31 | $1.20B | $0.19B | 6.28 |
| 2010-12-31 | $1.15B | $0.25B | 4.64 |
| 2010-09-30 | $1.07B | $0.29B | 3.73 |
| 2010-06-30 | $0.99B | $0.31B | 3.15 |
| 2010-03-31 | $1.03B | $0.33B | 3.17 |
| 2009-12-31 | $0.93B | $0.24B | 3.86 |
| 2009-09-30 | $0.94B | $0.29B | 3.22 |
| 2009-06-30 | $0.85B | $0.27B | 3.17 |
| 2009-03-31 | $0.73B | $0.23B | 3.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $36.905B | $4.685B |
| ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $234.530B | 28.20 |
| Boston Scientific (BSX) | United States | $156.880B | 39.27 |
| Stryker (SYK) | United States | $150.466B | 31.46 |
| EssilorLuxottica (ESLOY) | France | $133.537B | 0.00 |
| Medtronic (MDT) | Ireland | $110.863B | 16.19 |
| Lonza Group Ag (LZAGY) | Switzerland | $49.634B | 0.00 |
| Haleon (HLN) | United Kingdom | $48.687B | 27.69 |
| GE HealthCare Technologies (GEHC) | United States | $33.485B | 15.90 |
| Agilent Technologies (A) | United States | $32.436B | 21.43 |
| Terumo (TRUMY) | Japan | $27.642B | 35.90 |
| Insulet (PODD) | United States | $22.854B | 89.71 |
| Koninklijke Philips (PHG) | Netherlands | $22.587B | 16.24 |
| Zimmer Biomet Holdings (ZBH) | United States | $19.181B | 12.32 |
| Baxter (BAX) | United States | $16.247B | 12.13 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.648B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.767B | 23.55 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.18 |
| Prestige Consumer Healthcare (PBH) | United States | $4.402B | 19.67 |
| Perrigo (PRGO) | Ireland | $3.719B | 9.43 |
| Haemonetics (HAE) | United States | $3.532B | 15.39 |
| ICU Medical (ICUI) | United States | $3.480B | 25.66 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.097B | 25.73 |
| QuidelOrtho (QDEL) | United States | $2.263B | 15.56 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.81 |
| AtriCure (ATRC) | United States | $1.619B | 0.00 |
| Neogen (NEOG) | United States | $1.435B | 18.36 |
| Kestra Medical Technologies (KMTS) | United States | $1.264B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.217B | 12.36 |
| Green Thumb Industries (GTBIF) | United States | $1.182B | 26.59 |
| BioLife Solutions (BLFS) | United States | $1.121B | 0.00 |
| InMode (INMD) | Israel | $1.020B | 9.34 |
| Phibro Animal Health (PAHC) | United States | $0.973B | 12.44 |
| CeriBell (CBLL) | United States | $0.649B | 0.00 |
| Evolus (EOLS) | United States | $0.625B | 0.00 |
| Owens & Minor (OMI) | United States | $0.570B | 4.73 |
| Curaleaf Holdings (CURLF) | Canada | $0.553B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.535B | 0.00 |
| Valneva SE (VALN) | France | $0.524B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.498B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.431B | 0.00 |
| Surmodics (SRDX) | United States | $0.409B | 0.00 |
| SNDL (SNDL) | Canada | $0.355B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.335B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.325B | 11.94 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.321B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.305B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.288B | 51.30 |
| Sanara MedTech (SMTI) | United States | $0.280B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.267B | 22.53 |
| Cerus (CERS) | United States | $0.254B | 0.00 |
| ZimVie (ZIMV) | United States | $0.251B | 11.41 |
| Verano Holdings (VRNOF) | United States | $0.235B | 0.00 |
| Biote (BTMD) | United States | $0.224B | 6.31 |
| High Tide (HITI) | Canada | $0.191B | 0.00 |
| Omeros (OMER) | United States | $0.187B | 0.00 |
| Brainsway (BWAY) | Israel | $0.187B | 49.55 |
| Quanterix (QTRX) | United States | $0.186B | 0.00 |
| Organigram Global (OGI) | Canada | $0.182B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.182B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.181B | 14.58 |
| TriSalus Life Sciences (TLSI) | United States | $0.166B | 0.00 |
| Exagen (XGN) | United States | $0.128B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.77 |
| Jin Medical (ZJYL) | China | $0.125B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.113B | 0.00 |
| Agape ATP (ATPC) | $0.103B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.100B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.080B | 10.32 |
| Veru (VERU) | United States | $0.076B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.069B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.063B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.061B | 0.00 |
| United Health Products (UEEC) | United States | $0.061B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.056B | 0.00 |
| Apyx Medical (APYX) | United States | $0.054B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Modular Medical (MODD) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.039B | 13.35 |
| Rockwell Medical (RMTI) | United States | $0.035B | 0.00 |
| Safety Shot (SHOT) | United States | $0.031B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.023B | 30.86 |
| INLIF (INLF) | $0.018B | 0.00 | |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.011B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |